Literature DB >> 15953724

Inhibitors of the inducible microsomal prostaglandin E2 synthase (mPGES-1) derived from MK-886.

Denis Riendeau1, Renee Aspiotis, Diane Ethier, Yves Gareau, Erich L Grimm, Jocelyne Guay, Sébastien Guiral, Hélène Juteau, Joseph A Mancini, Nathalie Méthot, Joel Rubin, Richard W Friesen.   

Abstract

A series of potent and selective inhibitors of the inducible microsomal PGE2 synthase (mPGES-1) has been developed based on the indole FLAP inhibitor MK-886. Compounds 23 and 30 inhibit mPGES-1 with potencies in the low nanomolar range and with selectivities of at least 100-fold compared to their inhibition of mPGES-2, thromboxane synthase and binding affinity to FLAP. They also block the production of PGE2 in cell based assays but with a decreased potency and more limited selectivity compared to the enzyme assays.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15953724     DOI: 10.1016/j.bmcl.2005.05.027

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  33 in total

1.  Identification of a novel class of anti-inflammatory compounds with anti-tumor activity in colorectal and lung cancers.

Authors:  Hui-Hua Chang; Zuohe Song; Lee Wisner; Tina Tripp; Vijay Gokhale; Emmanuelle J Meuillet
Journal:  Invest New Drugs       Date:  2011-09-20       Impact factor: 3.850

Review 2.  Analgesic targets: today and tomorrow.

Authors:  Ian W Rodger
Journal:  Inflammopharmacology       Date:  2009-06-09       Impact factor: 4.473

3.  MK886 inhibits the proliferation of HL-60 leukemia cells by suppressing the expression of mPGES-1 and reducing prostaglandin E2 synthesis.

Authors:  YiQing Li; SongMei Yin; DaNian Nie; ShuangFeng Xie; LiPing Ma; XiuJu Wang; YuDan Wu; Jie Xiao
Journal:  Int J Hematol       Date:  2011-10-29       Impact factor: 2.490

4.  Targeting microsomal prostaglandin E synthase 1 to develop drugs treating the inflammatory diseases.

Authors:  Qian Wang; Yuanyuan Li; Mengying Wu; Songming Huang; Aihua Zhang; Yue Zhang; Zhanjun Jia
Journal:  Am J Transl Res       Date:  2021-01-15       Impact factor: 4.060

5.  Myrtucommulone, a natural acylphloroglucinol, inhibits microsomal prostaglandin E(2) synthase-1.

Authors:  A Koeberle; F Pollastro; H Northoff; O Werz
Journal:  Br J Pharmacol       Date:  2009-03       Impact factor: 8.739

6.  Resveratrol inhibits prostaglandin formation in IL-1beta-stimulated SK-N-SH neuronal cells.

Authors:  Lena Wendeburg; Antonio Carlos Pinheiro de Oliveira; Harsharan S Bhatia; Eduardo Candelario-Jalil; Bernd L Fiebich
Journal:  J Neuroinflammation       Date:  2009-09-14       Impact factor: 8.322

7.  Pharmacophore modeling and virtual screening for novel acidic inhibitors of microsomal prostaglandin E₂ synthase-1 (mPGES-1).

Authors:  Birgit Waltenberger; Katja Wiechmann; Julia Bauer; Patrick Markt; Stefan M Noha; Gerhard Wolber; Judith M Rollinger; Oliver Werz; Daniela Schuster; Hermann Stuppner
Journal:  J Med Chem       Date:  2011-04-20       Impact factor: 7.446

8.  Theoretical study of the regioselective cyclization of enaminones in the construction of benzofurans and indoles.

Authors:  Rafael Herrera; Francisco Méndez; Fabiola Jiménez; M Carmen Cruz; Joaquín Tamariz
Journal:  J Mol Model       Date:  2016-04-30       Impact factor: 1.810

Review 9.  Targeting inflammation: multiple innovative ways to reduce prostaglandin E₂.

Authors:  Jessica K Norberg; Earlphia Sells; Hui-Hua Chang; Srinivas R Alla; Shuxing Zhang; Emmanuelle J Meuillet
Journal:  Pharm Pat Anal       Date:  2013-03

Review 10.  Molecular communication between tumor-associated fibroblasts and head and neck squamous cell carcinoma.

Authors:  George Leef; Sufi Mary Thomas
Journal:  Oral Oncol       Date:  2013-01-26       Impact factor: 5.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.